News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
217 Results
Type
Article (43)
Company Profile (1)
Press Release (173)
Section
Business (103)
Deals (4)
Drug Development (40)
Job Trends (18)
News (135)
Policy (3)
Tag
Academia (1)
Alliances (29)
Best Places to Work (17)
Breast cancer (1)
Cancer (7)
CAR-T (1)
Cell therapy (4)
Clinical research (33)
Collaboration (1)
Compensation (1)
C-suite (4)
Data (6)
Earnings (29)
Events (21)
Funding (2)
GLP-1 (1)
Healthcare (3)
IPO (4)
Layoffs (1)
Legal (1)
Liver cancer (1)
Mergers & acquisitions (3)
Neuroscience (1)
NextGen: Class of 2026 (3)
People (44)
Pharmaceutical (1)
Phase 1 (22)
Phase 2 (10)
Phase 3 (12)
Pipeline (6)
Preclinical (2)
Regulatory (2)
Research institute (1)
Series A (1)
Series B (1)
Startups (4)
Vaccines (2)
Date
Last 30 days (2)
Last 365 days (22)
2026 (2)
2025 (20)
2024 (23)
2023 (18)
2022 (42)
2021 (18)
2020 (20)
2019 (11)
2018 (9)
2017 (6)
2016 (4)
2015 (5)
2014 (7)
2013 (7)
2012 (9)
2011 (1)
2010 (2)
Location
Asia (5)
California (1)
Delaware (1)
Europe (135)
Massachusetts (3)
Northern California (1)
Texas (23)
United States (28)
Washington State (1)
217 Results for "immatics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immatics Announces $125 Million Underwritten Offering
December 5, 2025
·
3 min read
Press Releases
Immatics Appoints Amie Krause as Chief People Officer
October 27, 2025
·
5 min read
Press Releases
Immatics Announces Third Quarter 2025 Financial Results and Business Update
November 18, 2025
·
21 min read
Press Releases
Immatics Appoints Venkat Ramanan as Chief Financial Officer
October 1, 2025
·
5 min read
Press Releases
Immatics Announces Second Quarter 2025 Financial Results and Business Update
August 13, 2025
·
18 min read
Press Releases
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
October 21, 2025
·
9 min read
Press Releases
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
December 11, 2025
·
10 min read
Press Releases
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
November 13, 2025
·
16 min read
Press Releases
Immatics Announces First Quarter 2025 Financial Results and Business Update
May 14, 2025
·
19 min read
Press Releases
Immatics Announces Full Year 2024 Financial Results and Business Update
March 28, 2025
·
24 min read
1 of 22
Next
